Victor C Kok Selected Research

Victor C Kok Research Topics

Disease

14	Neoplasms (Cancer) 06/2022 - 10/2007
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2014
3	Acute Kidney Injury (Acute Renal Failure) 01/2014 - 01/2012
2	Adenocarcinoma 01/2021 - 06/2018
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2015
2	Neoplasm Metastasis (Metastasis) 07/2019 - 01/2015
2	Bacteremia 02/2019 - 01/2017
2	Alcoholism (Alcohol Abuse) 01/2016 - 01/2014
2	Hemolytic Anemia 01/2014 - 01/2014
1	Triple Negative Breast Neoplasms 01/2022
1	Spinal Cord Compression 01/2021
1	Esophageal Neoplasms (Esophageal Cancer) 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Small Cell Carcinoma 01/2021
1	Ascites 01/2020
1	Squamous Cell Carcinoma of Head and Neck 01/2020
1	Iron Deficiencies 01/2020
1	Bites and Stings (Sting) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 07/2019
1	Ischemic Stroke 01/2019
1	Dementia (Dementias) 01/2019
1	Retinal Vein Occlusion 01/2019
1	Stomach Neoplasms (Stomach Cancer) 06/2018
1	Melanoma (Melanoma, Malignant) 09/2017
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2016
1	Coronary Disease (Coronary Heart Disease) 01/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Hypoglycemia (Reactive Hypoglycemia) 01/2016
1	Death (Near-Death Experience) 01/2016
1	Osteoporosis 01/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Asthma (Bronchial Asthma) 01/2015

Drug/Important Bio-Agent (IBA)

3	HydrocarbonsIBA 01/2019 - 01/2019
2	Long Noncoding RNAIBA 01/2022 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 10/2021 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2016
2	ProcalcitoninIBA 02/2019 - 01/2017
2	Lactic Acid (Lactate)FDA LinkGeneric 02/2019 - 01/2017
2	C-Reactive ProteinIBA 02/2019 - 01/2017
2	Air Pollutants (Pollutants, Air)IBA 01/2019 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2016 - 01/2015
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016 - 01/2015
1	Biological ProductsIBA 06/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	neratinibIBA 10/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	avelumabIBA 01/2020
1	durvalumabIBA 01/2020
1	sapropterin (tetrahydrobiopterin)FDA Link 01/2020
1	pembrolizumabIBA 01/2020
1	Cetuximab (Erbitux)FDA Link 01/2020
1	NivolumabIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	AntigensIBA 01/2020
1	ArginaseIBA 01/2020
1	atezolizumabIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Fluorouracil (Carac)FDA LinkGeneric 01/2020
1	GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2020
1	Immunoglobulins (Immunoglobulin)IBA 01/2020
1	InterferonsIBA 01/2020
1	KynurenineIBA 01/2020
1	LigandsIBA 01/2020
1	LipidsIBA 01/2020
1	PlatinumIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2020
1	Mucin-3IBA 01/2020
1	Cyclin DIBA 01/2020
1	Sorafenib (BAY 43-9006)FDA Link 07/2019
1	Volatile Organic CompoundsIBA 01/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	RamucirumabIBA 06/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2018
1	DesminIBA 09/2017
1	S100 Proteins (S 100 Protein)IBA 09/2017
1	pazopanib FDA Link 07/2016
1	CytokinesIBA 07/2016
1	Vitamin D FDA LinkGeneric 01/2016
1	taxaneIBA 01/2015
1	AnthracyclinesIBA 01/2015

Therapy/Procedure

6	Therapeutics 04/2021 - 01/2014
3	Immunotherapy 01/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2014
1	Radiotherapy 01/2021
1	Metastasectomy 04/2018
1	Palliative Care (Palliative Therapy) 01/2016
1	Hysterectomy 07/2015
1	Ovariectomy (Oophorectomy) 07/2015